CTCBIO Inc. (KOSDAQ:060590)
South Korea · Delayed Price · Currency is KRW 4,320.00
+70.00 (1.65%)
At close: Feb 20, 2026
CTCBIO Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 132,759 | 144,407 | 137,878 | 165,206 | 140,318 | 130,032 |
Other Revenue | -0 | -0 | -0 | -0 | -0 | -0 |
| 132,759 | 144,407 | 137,878 | 165,206 | 140,318 | 130,032 | |
Revenue Growth (YoY) | -4.46% | 4.74% | -16.54% | 17.74% | 7.91% | -4.47% |
Cost of Revenue | 78,862 | 91,539 | 95,309 | 111,150 | 107,228 | 103,643 |
Gross Profit | 53,897 | 52,868 | 42,570 | 54,056 | 33,090 | 26,389 |
Selling, General & Admin | 45,755 | 50,846 | 41,894 | 37,191 | 31,962 | 26,890 |
Research & Development | 2,347 | 3,558 | 2,639 | 2,414 | 3,090 | 3,907 |
Amortization of Goodwill & Intangibles | 87.4 | 81.93 | 96.74 | 296.67 | 414.05 | 265.12 |
Other Operating Expenses | 288.31 | 317.54 | 264.6 | 208.57 | 231.86 | 203.98 |
Operating Expenses | 48,341 | 56,821 | 47,148 | 42,826 | 36,027 | 32,266 |
Operating Income | 5,556 | -3,953 | -4,578 | 11,230 | -2,938 | -5,877 |
Interest Expense | -2,466 | -3,203 | -3,244 | -2,895 | -3,647 | -4,623 |
Interest & Investment Income | 338.01 | 532.28 | 725.08 | 251.11 | 118.76 | 149 |
Currency Exchange Gain (Loss) | -55.84 | 318.8 | 41.68 | -470.14 | -533.35 | 396 |
Other Non Operating Income (Expenses) | 275.64 | 1,753 | 689.17 | -2,374 | 1,952 | -12,408 |
EBT Excluding Unusual Items | 3,648 | -4,552 | -6,367 | 5,741 | -5,047 | -22,362 |
Gain (Loss) on Sale of Investments | -102.66 | -186.4 | -201.64 | -320.2 | -708.55 | -1,647 |
Gain (Loss) on Sale of Assets | 269.06 | 137.86 | 264.89 | -40.55 | 1.28 | 2,457 |
Asset Writedown | -719.3 | -719.3 | -9,411 | -5,181 | -1,337 | -740.28 |
Other Unusual Items | - | - | - | 0.01 | -595.12 | -445.38 |
Pretax Income | 3,095 | -5,319 | -15,715 | 199.42 | -7,687 | -22,738 |
Income Tax Expense | 445.16 | -99.03 | -126.83 | -4,504 | 291.74 | 130.18 |
Earnings From Continuing Operations | 2,650 | -5,220 | -15,588 | 4,704 | -7,978 | -22,868 |
Minority Interest in Earnings | - | - | - | - | 660.21 | 3,411 |
Net Income | 2,642 | -5,220 | -15,588 | 4,704 | -7,318 | -19,458 |
Net Income to Common | 2,642 | -5,220 | -15,588 | 4,704 | -7,318 | -19,458 |
Shares Outstanding (Basic) | 24 | 24 | 24 | 24 | 22 | 20 |
Shares Outstanding (Diluted) | 24 | 24 | 24 | 24 | 22 | 20 |
Shares Change (YoY) | -0.21% | - | 0.38% | 7.17% | 11.67% | 4.54% |
EPS (Basic) | 110.61 | -218.35 | -651.97 | 197.49 | -329.29 | -977.68 |
EPS (Diluted) | 110.61 | -218.35 | -652.00 | 197.00 | -329.29 | -978.00 |
Free Cash Flow | 10,150 | 2,357 | 6,331 | 15,051 | 4,783 | -1,414 |
Free Cash Flow Per Share | 424.97 | 98.58 | 264.80 | 631.92 | 215.23 | -71.04 |
Gross Margin | 40.60% | 36.61% | 30.88% | 32.72% | 23.58% | 20.29% |
Operating Margin | 4.18% | -2.74% | -3.32% | 6.80% | -2.09% | -4.52% |
Profit Margin | 1.99% | -3.62% | -11.31% | 2.85% | -5.21% | -14.96% |
Free Cash Flow Margin | 7.65% | 1.63% | 4.59% | 9.11% | 3.41% | -1.09% |
EBITDA | 12,252 | 1,951 | 1,368 | 17,936 | 3,344 | -61.44 |
EBITDA Margin | 9.23% | 1.35% | 0.99% | 10.86% | 2.38% | -0.05% |
D&A For EBITDA | 6,696 | 5,905 | 5,947 | 6,706 | 6,282 | 5,816 |
EBIT | 5,556 | -3,953 | -4,578 | 11,230 | -2,938 | -5,877 |
EBIT Margin | 4.18% | -2.74% | -3.32% | 6.80% | -2.09% | -4.52% |
Effective Tax Rate | 14.38% | - | - | - | - | - |
Advertising Expenses | - | 1,175 | 1,055 | 636.46 | 722.54 | 361.04 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.